Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Lipid Research

• Publication date

  1993-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8371058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Importance of Peroxisomes in the Formation of Chenodeoxycholic Acid in Human Liver. Metabolism of 3α,7α-Dihydroxy-5β-cholestanoic Acid in Zellweger Syndrome

  1991cited by this paper
• Importance of peroxisomes in the formation of chenodeoxycholic acid in human liver. Metabolism of 3 alpha,7 alpha-dihydroxy-5 beta-cholestanoic acid in Zellweger syndrome.

  1991cited by this paper
• Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.

  1991cited by this paper
• Identification of metabolites from peroxisomal beta-oxidation of prostaglandins.

  1990cited by this paper
• Peroxisomal chain-shortening of prostaglandin F2 alpha.

  1988cited by this paper
• Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.

  1988cited by this paper
• Peroxisomal chain-shortening of prostaglandin FZa

  1988cited by this paper
• Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes.

  1987cited by this paper
• A comparative study of stearic and lignoceric acid oxidation by human skin fibroblasts.

  1986cited by this paper
• Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs.

  1984cited by this paper
• Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans.

  1984cited by this paper
• Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites.

  1981cited by this paper
• Fatty acid products of peroxisomal beta-oxidation.

  1980cited by this paper
• Tetranor thromboxane B2 is the principal urinary catabolite formed after i.v. infusion of thromboxane B2 in the rat.

  1980cited by this paper
• Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.

  1980cited by this paper
• Fatty acid products of peroxisomal β-oxidation

  1980cited by this paper
• Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.

  1980cited by this paper
• Metabolism of the prostaglandins and thromboxanes.

  1980cited by this paper
• Rat liver peroxisomes catalyze the beta oxidation of fatty acids.

  1978cited by this paper
• Inhibitors of thromboxane synthase in human platelets

  1977cited by this paper
• Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite.

  1977cited by this paper
• Identification of the major urinary metabolite of thromboxane B2 in the monkey.

  1977cited by this paper
• Metabolism of thromboxane B2 in the cynomolgus monkey.

  1977cited by this paper
• Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2.

  1976cited by this paper
• A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

  1976cited by this paper
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

  1975cited by this paper
• Carnitine-dependent oxidation of prostaglandins.

  1972cited by this paper
• Metabolism of prostaglandins in rat liver mitochondria.

  1968cited by this paper

• Fatty Acid Metabolism in Peroxisomes and Related Disorders.

  2024cites this paper
• The peroxisome: an up-and-coming organelle in immunometabolism.

  2022cites this paper
• Functions of ROS in Macrophages and Antimicrobial Immunity

  2021cites this paper
• Gut microbial metabolites of linoleic acid are metabolized by accelerated peroxisomal β-oxidation in mammalian cells.

  2019cites this paper
• "Role of peroxisomes in human lipid metabolism and its importance for neurological development".

  2017cites this paper
• Peroxisomes in Humans: Metabolic Functions, Cross Talk with Other Organelles, and Pathophysiology of Peroxisomal Disorders

  2014cites this paper
• Peroxisomes in human health and disease: metabolic pathways, metabolite transport, interplay with other organelles and signal transduction.

  2013cites this paper
• Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism

  2010cites this paper
• Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism[S]

  2010cites this paper
• Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid

  2009cites this paper
• Functions and Dysfunctions of Peroxisomes in Fatty Acid α- and β-Oxidation

  2002cites this paper
• Lipid metabolism in peroxisomes in relation to human disease.

  1998cites this paper
• PEROXISOMAL HEREDITARY DISEASES

  1997cites this paper
• beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress.

  1995cites this paper
• Measurement of peroxisomal fatty acid β-oxidation in cultured human skin fibroblasts

  1995cites this paper
• Beta-oxidation of eicosanoids.

  1994cites this paper
• Impaired Degradation of Prostaglandins and Thromboxane in Zellweger Syndrome

  1994cites this paper
• β-Oxidation of eicosanoids

  1994cites this paper